Form 4: Encompass Health Director Leslye G. Katz Acquires Shares Through Dividend Reinvestment

Sentiment:

SEC Form 4 Filing


Director Leslye G. Katz acquired 83 shares of Encompass Health Corp through a dividend reinvestment program.

Summary

  • Leslye G. Katz, a director at Encompass Health Corp, acquired 83 shares of common stock on January 15, 2025.
  • The acquisition was a result of a dividend reinvestment program where additional restricted stock units (RSUs) are credited to non-employee directors' accounts based on dividend payments.
  • The dividend paid was $0.17 per share, and the closing price of the stock on the dividend payment date was $93.61.
  • The total number of shares beneficially owned by Ms. Katz after this transaction is 46,105.

Sentiment

Score: 7

Explanation: The document reflects a routine transaction, indicating a positive but not extraordinary sentiment. The director's participation in the dividend reinvestment program is a positive sign of confidence in the company.

Positives

  • The acquisition of shares by a director through dividend reinvestment demonstrates confidence in the company's future.
  • The dividend reinvestment program allows directors to increase their stake in the company.

Industry Context

This is a standard transaction for directors of publicly traded companies who participate in dividend reinvestment programs. It reflects a common practice of aligning director interests with shareholder interests.

Comparison to Industry Standards

  • Dividend reinvestment programs are a common practice among publicly traded companies, including those in the healthcare sector like Encompass Health.
  • Many companies offer similar programs to their directors and employees as a way to encourage long-term investment in the company's stock.
  • The specific mechanics of the RSU crediting based on dividend payments are typical of such programs.

Stakeholder Impact

  • The transaction has a minor positive impact on shareholders as it demonstrates director confidence in the company.
  • The dividend reinvestment program aligns director interests with those of shareholders.

Key Dates

DateDescription
01/15/2025Date of the transaction where Leslye G. Katz acquired 83 shares of Encompass Health stock through dividend reinvestment.
01/17/2025Date the Form 4 was signed by Patrick Darby, attorney-in-fact for Leslye G. Katz.

Keywords

Encompass Health, Director, Leslye G. Katz, Dividend Reinvestment, Restricted Stock Units, RSUs, Share Acquisition, Form 4

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.